Skip to main content
Premium Trial:

Request an Annual Quote

Kreatech, BioMicro Set European Distribution Pact

NEW YORK (GenomeWeb News) — Kreatech has begun distributing BioMicro Systems' products in Germany, France, and in the BeNeLux regions, where the company's sales organization is based. The companies also are engaging in a development collaboration.

The agreement is structured similarly to a 2007 agreement between the two companies that enables BioMicro to distribute Kreatech's Universal Linkage System labeling portfolio in the US.

Kreatech VP of Sales and Marketing Harald Berninger said in a statement that BioMicro's microfluidic and microarray technologies "address the same customer segment as the one we have been targeting with our … ULS labeling technology."

BioMicro CEO Michael Feldman added that the companies are collaborating to develop technologies for the cytogenetics market. Berninger said that BioMicro's Maui hybridization and washing systems potentially could be used in cytogenetics, and that the companies may co-develop new products and specific applications in that area.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.